seminest
rtpcr
nrtpcr
use
detect
picornaviru
pv
rna
cell
cultur
inocul
rhinovirus
hrv
enterovirus
ev
pcr
test
n
primari
touchdown
pcr
follow
secondari
reaction
use
pv
hrv
specif
primer
abl
differenti
hrv
serotyp
ev
pvnrtpcr
hrvnrtpcr
use
test
nasal
throat
swab
adult
subject
natur
acquir
respiratori
viru
infect
swab
also
analys
respiratori
virus
cell
cultur
techniqu
rate
pv
identif
two
method
compar
pvnrtpcr
found
least
five
time
sensit
cell
cultur
detect
pv
n
clinic
specimen
pair
acut
convalesc
serum
sampl
test
complement
fix
antibodi
adenoviru
influenza
b
respiratori
syncyti
viru
parainfluenza
virus
myco
plasma
pneumonia
chlamydia
psittaci
enzymelink
immunosorb
assay
elisa
use
detect
rise
antibodi
level
coronaviru
type
overal
rate
pathogen
identif
swab
adult
asthmat
increas
cell
cultur
serolog
use
method
supplement
pvnrtpcr
wileyliss
inc
common
cold
major
caus
morbid
loss
work
drug
expenditur
year
averag
preschool
child
cold
averag
adult
cold
sperber
hayden
research
effect
cold
normal
individu
chronic
lung
diseas
hamper
consider
dieculti
encount
identifi
respiratori
pathogen
human
rhinovirus
hrv
major
caus
agent
common
cold
couch
ogi
screen
hamparian
et
al
rate
viru
identif
rare
greater
minor
colleagu
recov
hrv
specimen
young
asthmat
children
symptomat
respiratori
infect
abl
isol
hrv
specimen
older
patient
minor
et
al
rate
total
viru
identif
studi
use
varieti
diagnost
method
nucleic
acid
hybrid
techniqu
particularli
base
polymeras
chain
reaction
saiki
et
al
use
rapid
detect
virus
slowgrow
organ
hayden
et
al
sever
short
conserv
region
untransl
section
picornaviru
pv
genom
duechler
et
al
hugh
et
al
provid
sequenc
oligonucleotid
probe
primer
gama
et
al
gama
et
al
hyypia
et
al
torgersen
et
al
four
region
ad
shown
fig
radiolabel
synthet
oligonucleotid
probe
complementari
c
use
bruce
colleagu
detect
rna
hrv
serotyp
identifi
infect
nasal
wash
experiment
infect
volunt
probe
gave
result
compar
convent
viru
cultur
day
two
three
postinocul
sensit
cultur
subsequ
day
neg
result
obtain
unrel
respiratori
virus
includ
reovirus
influenza
virus
coronaviru
herp
simplex
viru
oligonucleotid
complementari
c
use
revers
transcriptas
backward
pcr
primer
sever
group
worker
gama
et
al
gama
et
al
hyypia
et
al
torgersen
et
al
group
use
part
conserv
sequenc
forward
pcr
primer
gama
colleagu
obtain
posit
result
nasal
wash
volunt
experiment
infect
reaction
product
versiti
subject
adult
two
group
healthi
student
third
group
asthmat
ethic
committe
amrov
sign
inform
u
consent
obtain
fig
four
conserv
region
region
rhinovirus
provid
sequenc
oligonucleotid
probe
rtpcr
primer
number
shown
stanway
et
al
analys
agaros
gel
electrophoresi
reaction
cycl
characteris
nucleotid
sequenc
complementari
sequenc
region
b
use
hyypia
et
al
hrv
probe
southern
blot
report
result
wildtyp
pv
isol
clinic
materi
llc
hela
cell
except
one
gave
amplif
product
expect
size
product
hrv
hybrid
probe
oliv
et
al
use
sequenc
forward
pcr
primer
revers
transcriptas
backward
pcr
primer
complementari
sequenc
downstream
region
reaction
product
identifi
sole
size
seen
ethidium
bromidestain
agaros
gel
hrv
could
differenti
pv
method
pcr
product
bp
hrv
bp
poliovirus
coxsackievirus
echovirus
worker
use
pcr
directli
nasal
swab
confin
effort
specimen
posit
respiratori
virus
cell
cultur
devis
seminest
rtpcr
nrtpcr
improv
sensit
specif
method
pv
detect
pcr
use
primer
sequenc
primer
complementari
sequenc
touchdown
reaction
cycl
reduc
spuriou
prime
et
al
pcr
use
primer
sequenc
togeth
primer
complementari
either
b
hrvnrtpcr
c
pvnrtpcr
use
differenti
hrv
pv
appli
test
directli
nasal
throat
swab
control
individu
natur
acquir
cold
compar
rate
pv
detect
pvnrtpcr
cell
cultur
clinic
sampl
taken
volunt
two
studi
leicest
univers
one
cardiff
uni
subject
leicest
ask
record
symptom
diari
card
describ
previous
wiselka
et
al
symptom
use
handkerchief
runni
nose
stuffi
nose
sneez
sore
throat
hoars
red
wateri
eye
face
head
earach
malais
muscl
ach
chill
cough
pain
swollen
neck
gland
symptomat
day
two
symptom
record
least
one
symptom
moder
sever
wors
number
symptomat
day
total
symptom
score
ten
day
use
measur
sever
cold
subject
doubt
cold
exclud
studi
group
volunt
cardiff
selfdiagnos
suffer
cold
select
studi
basi
symptom
score
nasal
swab
place
high
anterior
nare
throat
swab
pass
firmli
pharynx
tonsil
swab
place
togeth
ml
viru
transport
medium
contain
nutrient
broth
foetal
calf
serum
penicillin
streptomycin
amphotericin
b
specimen
store
volum
ml
nasal
throat
swab
inocul
onto
monolay
ohio
hela
cell
human
lung
fibroblast
cell
cell
line
deriv
fibroblast
suscept
coronaviru
madindarbi
canin
kidney
mdck
cell
cell
line
cultur
roller
tube
coz
observ
day
specimen
inocul
onto
ohio
hela
cell
routin
passag
day
equivoc
specimen
passag
three
time
hrv
infect
diagnos
observ
characterist
cytopath
effect
cpe
posit
isol
hrv
confirm
demonstr
characterist
acid
labil
inhibit
cpe
influenza
virus
identifi
haemadsorpt
inhibit
mdck
cell
pv
known
serotyp
obtain
mrc
common
cold
unit
salisburi
uk
also
cultur
echovirus
coxsacki
virus
grown
cell
hrv
hela
cell
pair
acut
convalesc
sera
test
complement
fix
antibodi
adenoviru
influenza
b
respiratori
syncyti
viru
parainfluenza
virus
mycoplasma
pneumonia
chlamydia
psittaci
exzymelink
immunosorb
assay
elisa
kraaijeveld
et
al
use
detect
rise
antibodi
level
coronaviru
similar
elisa
use
antigen
prepar
infect
suckl
mous
brain
use
detect
antibodi
coronaviru
sampl
pl
cell
cultur
grown
viru
nasal
throat
swab
transport
medium
use
nucleic
acid
extract
materi
transfer
immedi
thaw
ml
reaction
tube
contain
pg
proteinas
k
pg
carrier
trna
x
proteinas
k
buffer
mm
ph
mm
edta
sd
appropri
neg
control
alway
includ
incub
min
sampl
extract
phenol
chloroform
twice
chloroform
nucleic
acid
precipit
addit
pl
sodium
acet
ph
ml
cold
ethanol
tube
min
ice
reaction
tube
centrifug
min
microfug
kept
result
pellet
wash
ethanol
air
dri
resuspend
cdna
synthesi
mixtur
primer
pcr
follow
sequenc
sequenc
oligonucleotid
probe
pcr
primer
cdna
synthesi
cdna
synthesi
mixtur
use
resuspend
extract
nucleic
acid
contain
mm
ph
mm
mm
mgcl
mm
dtt
mm
dntp
rnaguard
ribonucleas
inhibitor
pharmacia
mmlv
revers
transcriptas
gibcobrl
uireact
rtipcrprim
pm
reaction
tube
incub
hr
transfer
n
ice
bath
pl
portion
revers
transcript
reaction
dilut
pl
pcr
amplif
reaction
tube
contain
mm
ph
mm
kcl
mm
mgcl
mm
dntp
taq
polymeras
cambio
ukeact
bsa
brl
pg
primer
rtipcrand
pcr
pm
touchdown
reaction
cycl
use
et
al
step
sec
interv
sec
min
two
cycl
anneal
temperatur
follow
cycl
amount
pl
pcr
product
transfer
new
tube
contain
pcr
reaction
mixtur
except
inclus
primer
pcr
pv
pcr
pvnrtpcr
pcr
hrv
ypcr
hrvnrtpcr
reagent
ireland
et
al
use
pcr
reaction
cycl
sec
sec
min
cycl
repeat
time
reaction
product
separ
agaros
gel
contain
ethidium
bromid
visual
fluoresc
ultraviolet
light
pcr
product
transfer
posit
charg
nylon
membran
amersham
hybondn
alkalin
blot
filter
prehybrid
hr
x
ssc
x
denhardt
solut
sd
pgml
singlestrand
her
sperm
dna
calcul
melt
temperatur
probe
use
oligonucleotid
probe
endlabel
use
polynucleotid
kinas
sigma
p
p
amersham
precursor
label
probe
separ
unincorpor
atp
column
sephadex
pharmacia
label
probe
ad
prehybrid
mixtur
contain
filter
allow
hybrid
overnight
calcul
hybrid
filter
wash
twice
x
ssc
sd
min
room
temperatur
twice
x
ssc
sd
min
hybrid
temperatur
filter
autoradiograph
xray
film
kodak
xomat
ar
overnight
rna
extract
hrv
enterovirus
ev
known
serotyp
grown
cell
cultur
revers
transcriptas
pcr
primer
chosen
conserv
region
shown
fig
use
give
bp
amplif
product
pv
gama
et
al
southern
blot
pcr
product
probe
oligonucleotid
probe
calcul
melt
temperatur
pv
probe
complementari
region
c
hrv
probe
complementari
region
b
hyypia
et
al
hrv
coxsacki
virus
gave
expect
pcr
product
six
seven
echovirus
absenc
reaction
product
echoviru
expect
gama
et
al
hyypia
et
al
pv
probe
react
pcr
product
except
hrv
probe
bind
product
ev
bind
hrv
pcr
product
pcr
product
ev
hrv
later
reamplifi
use
hrv
probe
revers
primer
none
ev
gave
product
hrv
nrtpcr
hrv
includ
given
posit
result
label
probe
gave
expect
ypcr
product
result
clinic
sampl
summar
tabl
nasal
throat
swab
leicest
univers
volunt
high
symptom
score
chosen
analysi
pvnrtpcr
pv
cultur
specimen
although
two
hrv
one
echoviru
isol
subject
studi
seven
posit
swab
detect
pcr
product
analyz
southern
blot
hybridis
label
probe
seven
react
pv
probe
five
hrv
probe
small
amount
pcr
product
reamplifi
use
pv
probe
revers
primer
five
posit
swab
detect
thu
nasal
throat
swab
neg
pv
cell
cultur
posit
pvnrtpcr
use
adenoviru
isol
one
remain
swab
volunt
show
serolog
evid
influenza
b
infect
thu
use
pvnrtpcr
detect
pv
increas
overal
rate
pathogen
identif
pvnrtpcr
hrv
nrtpcr
use
analys
nasal
throat
swab
particip
cardiff
univers
studi
patient
cold
healthi
control
swab
test
random
order
ident
known
investig
experi
finish
swab
gave
posit
result
extract
revers
transcrib
amplifi
confirm
find
eleven
patient
swab
posit
pv
six
amplifi
pcr
thu
identifi
hrv
wherea
none
swab
healthi
control
posit
either
nrtpcr
one
patient
swab
posit
pv
test
pvnrtpcr
also
posit
cell
cultur
five
pvneg
patient
swab
respiratori
pathogen
identifi
serolog
two
posit
coronaviru
two
influenza
viru
one
adenoviru
rate
pathogen
identif
increas
use
pvnrtpcr
pvnrtpcr
hrv
nrtpcr
also
analys
nasal
throat
swab
subject
volunt
prospect
studi
respiratori
infect
patient
asthma
sixti
swab
taken
patient
cold
posit
pv
test
pvnrtpcr
pcr
product
also
reamplifi
use
hrv
pcrprimer
thu
identifi
hrv
thirteen
nasal
throat
swab
posit
hrv
hrv
nrtpcr
also
posit
hrv
cell
cultur
three
coinfect
hrv
identifi
hrv
nrtpcr
anoth
viru
identifi
serolog
one
subject
coinfect
hcv
rs
viru
identifi
serolog
overal
rate
pathogen
identif
increas
use
pvnrtpcr
convalesc
nasal
throat
swab
taken
least
week
acut
swab
three
convalesc
swab
subject
hrvposit
acut
swab
gave
posit
reaction
evalu
result
studi
consider
must
first
given
commonli
voic
critic
pcrit
particular
suscept
fals
posit
result
due
contamin
lo
et
al
attempt
identifi
possibl
sourc
contamin
adopt
suitabl
procedur
elimin
separ
set
pipettor
use
prepar
mixtur
reagent
aerosol
resist
pipett
tip
continent
laboratori
product
use
throughout
differ
area
laboratori
use
add
pcr
substrat
run
agaros
gel
contain
pcr
product
neg
control
cell
cultur
includ
sever
time
everi
assay
never
gave
product
extract
revers
transcript
amplif
carryov
observ
even
specimen
contain
larg
number
cell
culturegrown
viru
particl
process
alongsid
neg
control
nasal
throat
swab
control
subject
without
cold
symptom
test
togeth
swab
patient
cold
none
control
sampl
gave
posit
result
nrtpcr
assay
simpl
rna
extract
method
essenti
mani
specimen
process
simultan
rtpcr
gama
colleagu
use
method
requir
seven
solvent
extract
addit
carrier
trna
vanadyl
ribonucleosid
complex
found
unnecessari
add
ribonucleas
inhibitor
specimen
reaction
proteinas
k
sdscontain
buffer
ad
clinic
materi
immedi
thaw
follow
enzym
digest
use
three
solvent
extract
one
phenolichloroform
two
chloroform
ethanolacet
precipit
nucleic
acid
pcr
rhinoviru
detect
describ
group
worker
gama
et
al
gama
et
al
hyypia
et
al
torgersen
et
al
cycl
anneal
temperatur
amplif
condit
use
studi
domin
product
frequent
variou
altern
fragment
less
bp
long
touchdown
pcr
describ
colleagu
method
prevent
spuriou
prime
gene
amplif
use
pcr
anneal
temperatur
decreas
everi
second
cycl
touchdown
temperatur
follow
cycl
product
spuriou
product
inhibit
possibl
use
nest
primer
pcr
confirm
specif
reaction
increas
sensit
test
oligonucleotid
probe
use
experi
abl
distinguish
properli
ev
hrv
sinc
hrv
probe
incomplet
reactiv
serotyp
test
incomplet
reactiv
hrv
serotyp
agre
observ
hyypia
colleagu
use
less
stringent
condit
probe
react
clinic
isol
hrv
surprisingli
hrv
l
b
pcr
product
hydrid
hrv
probe
although
previous
publish
sequenc
nucleotid
hrv
l
b
show
perfect
complementar
probe
torgersen
et
al
variat
may
exist
untransl
region
isol
hrv
serotyp
polioviru
serotyp
minor
dunn
problem
restrict
reactiv
hrv
serotyp
cell
cultur
overcom
use
oligonucleotid
pcr
primer
n
anneal
temperatur
hrv
pcr
product
includ
fail
hybrid
probe
gave
pcr
product
wherea
none
ev
amplifi
sommer
tautz
found
primer
length
nucleotid
need
least
three
homolog
nucleotid
success
prime
remaind
primer
need
surprisingli
littl
homolog
target
sequenc
although
pv
identifi
pvnrtpcr
swab
asthmat
could
type
hrv
hrvnrtpcr
five
pcr
product
cardiff
subject
cold
reamplifi
pv
hrv
pcr
primer
ohio
hela
cell
cultur
yield
viru
swab
taken
within
period
patient
may
infect
one
sever
enterovirus
associ
mild
ill
upper
respiratori
tract
includ
coxsacki
virus
echovirus
also
possibl
viru
virus
respons
hrv
recogn
hrv
pcrprimer
studi
shown
pvnrtpcr
least
five
time
sensit
cell
cultur
detect
pv
nasal
throat
swab
pvnrtpcr
also
consider
faster
sinc
whole
process
complet
less
two
work
day
amplif
directli
clinic
materi
mean
cell
cultur
unnecessari
nrtpcr
expens
tradit
method
viru
isol
although
cell
culturegrown
hrv
test
could
differenti
pv
use
hrvnrtpcr
remain
possibl
true
hrv
import
pv
hrv
primer
use
pcr
hrv
suffici
larg
number
hrv
clinic
materi
identifi
method
cell
cultur
restrict
enzym
analysi
hrv
pcr
product
torgersen
et
al
enabl
us
determin
whether
viru
found
convalesc
nasal
throat
swab
ident
found
correspond
acut
specimen
way
gain
inform
persist
hrv
infect
fact
mani
specimen
neg
pv
cell
cultur
posit
test
pvnrtpcr
signific
implic
futur
work
epidemiolog
potenti
therapi
respiratori
tract
infect
